AMED Company Profile and Key Details

Q: Who are the executives of AMED?

Ms. Denise BohnertChief Compliance OfficerMr. Scott G. GinnExecutive Vice President, Chief Financial Officer & Acting Chief Operating OfficerMr. Michael P. NorthChief Information OfficerMs. Janet BrittSenior Vice President of Billing & CollectionsMr. Adam HoltonChief People OfficerMr. Paul Berthold KusserowChairman & Chief Executive OfficerKendra KimmonsVice President of Marketing & Communications & Media RelationsMr. Pete HartleyChief Technology Officer & Senior Vice President of Bus. Operations SystemsMr. John NugentChief Acquisitions OfficerMr. Richard M. AshworthPres, Chief Executive Officer & DirectorMr. Nick MuscatoChief Strategy OfficerMs. Jennifer Guckert GriffinSenior Vice President, Deputy Gen. Counsel, Corporation Sec. & Interim Chief Legal OfficerMr. Francis MayerSenior Vice President of Devel.

NASDAQ : AMED

Amedisys

$100.99

0.01+0.01%

At Close 4:00 PM

Not Actively Trading

75.05

B+ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Amedisys, Inc. (AMED) stock surged +0.01%, trading at $100.99 on NASDAQ, up from the previous close of $100.98. The stock opened at $101.00, fluctuating between $100.93 and $101.02 in the recent session.

Stock Snapshot

100.98

Prev. Close

3.32B

Market Cap

100.93

Day Low

39.295719844357976

P/E Ratio

2.57

EPS (TTM)

2.78

Cash Flow per Share

101

Open

32.89M

Number of Shares

101.02

Day High

98.02%

Free Float in %

33.31

Book Value

1.04M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 15, 2025	100.99	100.99	100.99	100.99	0
Aug 14, 2025	101.02	101.02	100.93	100.99	1.06M
Aug 13, 2025	100.96	101.00	100.73	100.98	579.68K
Aug 12, 2025	100.94	100.97	100.86	100.95	866.1K
Aug 11, 2025	100.95	101.01	100.85	100.96	880.8K
Aug 08, 2025	100.88	100.97	100.84	100.94	684.12K
Aug 07, 2025	99.35	100.99	98.96	100.88	3.41M
Aug 06, 2025	99.23	99.87	99.06	99.29	821.14K
Aug 05, 2025	98.50	99.85	98.30	99.31	1.41M
Aug 04, 2025	98.77	98.91	98.14	98.50	555.03K
Aug 01, 2025	98.18	98.96	98.09	98.51	872.14K
Jul 31, 2025	98.13	99.00	98.13	98.60	528.5K
Jul 30, 2025	98.40	98.77	97.66	98.69	1.03M
Jul 29, 2025	97.13	97.66	96.88	97.52	395.2K
Jul 28, 2025	98.20	98.20	96.72	96.91	772.13K
Jul 25, 2025	98.31	98.31	97.45	97.94	417.52K
Jul 24, 2025	97.67	98.10	97.52	97.83	391.97K
Jul 23, 2025	98.00	98.04	97.77	97.77	207.42K
Jul 22, 2025	97.55	98.01	97.55	97.97	290.6K
Jul 21, 2025	97.56	97.96	97.56	97.71	178.67K

Contact Details

Baton Rouge, LA 70816

United States

https://www.amedisys.com 225 292 2031

About Company

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Stock Peers

ENSG

1.49+0.75%

The Ensign Group, Inc.$199.29 ADUS

-2.17-2.05%

Addus HomeCare Corporation$103.71 FSHCX

-0.9-0.91%

Health Care Services Portfolio$98.03 AMEH

-0.88-2.11%

Apollo Medical Holdings, Inc.$40.82 OPCH

-0.83-2.44%

Option Care Health, Inc.$33.17 PNTG

0.45+1.48%

The Pennant Group, Inc.$30.80 MCTA

1.855+6.75%

Charming Medical Limited Class A Ordinary Shares$29.36 HCSG

-0.44-2.27%

Healthcare Services Group, Inc.$18.96 KDLYW

2.995+19.14%

Kindly MD, Inc.$18.65 ASTH

-2.51-11.90%

Astrana Health, Inc.$18.59

Company Overview

Amedisys, Inc. (NASDAQ:AMED) closed at $100.99 USD, gaining $0.01 (0.01%) from the previous close of $100.98. The stock is currently trading near its 52-week high $82.15 and $101.02. With a market capitalization of about $3.32 billion, Amedisys, Inc. is classified as a mid-cap and shows market-like volatility (beta ~0.90). Key stats such as the average daily volume over the past year has been around 517.90 thousand shares, trading with heavier-than-usual volume. Headquartered in Baton Rouge, LA, Amedisys, Inc. operates in the Healthcare sector and the Medical - Care Facilities industry. Led by CEO Richard M. Ashworth, the company employs approximately 19,000 people and listed since August 17, 1994. Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States.

Technical Performance

Short-term trend indicators are bearishly aligned (SMA20 2.03%, SMA50 3.3%, SMA200 8.12%). The stock’s 14-day RSI is 74.65 (overbought), while the ATR of 0.68 points to tighter daily ranges. The stock remains sitting in the mid-range of its 52-week band, trading -0.03% below its high and over 22.93% above its low.

Valuation Metrics

Amedisys, Inc. trades at a P/E ratio of 22.16, slightly below the S&P 500 average, with a price-to-sales ratio of 1.38 and a price-to-book ratio of 2.69 suggesting the stock is closer to book value. The P/FCF stands at 14.18, also above market averages.

Dividend & Fair Value

Amedisys, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $112.84. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Amedisys, Inc. generated EPS of $2.57 over the past year. Five-year average earnings growth is -19.4%. The latest quarter delivered EPS of $1.54. The next quarter is forecast at $1.14. Next year's EPS is expected at $3.01. Analyst sentiment is neutral. Analyst rating data shows there are 0 Strong Buy ratings, 0 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $101.00 to $101.00. The high target offers 0.01% upside. The low target suggests 0.01% downside. The mean target is $101.00. This offers 0.01% upside. Amedisys, Inc. earnings surprise history is a mixed track record. The quarter that ended July 29, 2025, missed forecasts by 10.79%. The prior quarter beat by 10.62%. Over the last six quarters, Apple has recorded several small beats. These include 0.98% in April 24, 2024.

Shareholding & Insider Activity

Amedisys, Inc. has 32.89 million shares outstanding. The public float is 32.24 million shares, elevated short interest at 9.90% of float. This equals 3.20 million shares. The short ratio is 6.84 days. Institutional investors hold 98.29% of the float. Insiders own 1.95%. Gerard Christopher holds 37.86 thousand shares, Ginn Scott G has 29.11 thousand shares and PERKINS BRUCE D has 17.87 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Amedisys generated $2.24B in revenue, or $68.60 per share. Gross margin was 20.44%, operating margin 8.63%, and net profit margin -0.44%. Returns are negative, with ROA at -0.47% and ROE at -0.91%.
On valuation metrics, Amedisys trades at a P/E of 22.16, P/S of 1.38 and P/B of 2.69. The current ratio is 1.36 and quick ratio is 1.36. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 35.42 days. Debt-to-equity is 0.37, supported by a cash flow-to-debt ratio of 0.53.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Amedisys posted revenue of $2.24B, down slightly from $2.22B in the prior quarter. Gross profit was $457.08M (margin 20.44%). Operating income was $193.07M (margin 8.6%). Net income was- $9.75M (EPS - $0.30).
The company ended the quarter with $145.86M in cash and short-term investments, a total debt of $487.21M, and net debt of $341.35M. Total assets were $2.06B, with equity of $1.12B. Financials further reflected stability, with operating cash flow of $137.19M, free cash flow of $124.48M, and capital expenditures of - $12.71M.

Price Forecast & Outlook

Our AI price prediction model suggests that Amedisys, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.32%, with price expected at $104.34 by August 29, 2025, within a range of $103.47 to $105.23 3-Month Outlook: Projected rise of 31.63%, reaching $132.93 by November 13, 2025, with a range of $129.27 to $136.66. 1-Year Outlook: Projected loss of -4.52%, with price at $96.43 by August 14, 2026, within a range of $92.59 to $99.97.

Key Takeaways

Amedisys, Inc. (NASDAQ:AMED) shares are up 11.23% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Amedisys, Inc. trading at a premium to the broader market with a P/E of 22.16. Analyst sentiment is cautious, with the majority of ratings in Equal-Weight territory and a mean price target of $131.72, suggesting 30.43% upside. Our AI forecast model points to short-term strength (3.32% over two weeks), a medium-term rise (31.63% over three months), and a longer-term loss (-4.52% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Amedisys, Inc. (AMED) stock price?

Amedisys, Inc. (NASDAQ: AMED) stock price is $100.99 in the last trading session. During the trading session, AMED stock reached the peak price of $101.02 while $100.93 was the lowest point it dropped to. The percentage change in AMED stock occurred in the recent session was 0.01% while the dollar amount for the price change in AMED stock was $0.01.

AMED's industry and sector of operation?

The NASDAQ listed AMED is part of Medical - Care Facilities industry that operates in the broader Healthcare sector. Amedisys, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AMED?

Ms. Denise Bohnert
Chief Compliance Officer
Mr. Scott G. Ginn
Executive Vice President, Chief Financial Officer & Acting Chief Operating Officer
Mr. Michael P. North
Chief Information Officer
Ms. Janet Britt
Senior Vice President of Billing & Collections
Mr. Adam Holton
Chief People Officer
Mr. Paul Berthold Kusserow
Chairman & Chief Executive Officer
Kendra Kimmons
Vice President of Marketing & Communications & Media Relations
Mr. Pete Hartley
Chief Technology Officer & Senior Vice President of Bus. Operations Systems
Mr. John Nugent
Chief Acquisitions Officer
Mr. Richard M. Ashworth
Pres, Chief Executive Officer & Director
Mr. Nick Muscato
Chief Strategy Officer
Ms. Jennifer Guckert Griffin
Senior Vice President, Deputy Gen. Counsel, Corporation Sec. & Interim Chief Legal Officer
Mr. Francis Mayer
Senior Vice President of Devel.

How AMED did perform over past 52-week?

AMED's closing price is 22.93% higher than its 52-week low of $82.15 where as its distance from 52-week high of $101.02 is -0.03%.

How many employees does AMED have?

Number of AMED employees currently stands at 19,000.

Link for AMED official website?

Official Website of AMED is: https://www.amedisys.com

How do I contact AMED?

AMED could be contacted at phone 225 292 2031 and can also be accessed through its website. AMED operates from 3854 American Way, Baton Rouge, LA 70816, United States.

How many shares of AMED are traded daily?

AMED stock volume for the day was 1.04M shares. The average number of AMED shares traded daily for last 3 months was 517.9K.

What is the market cap of AMED currently?

The market value of AMED currently stands at $3.32B with its latest stock price at $100.99 and 32.89M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	19000
Beta	0.9
Sales or Revenue	$2.24B
5Y Sales Change%	0.358%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Care Facilities

AMED Company Profile and Key Details

Amedisys

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook